Fighting Neisseria meningitidis: past and current vaccination strategies.

about

Analysis of novel meningococcal vaccine formulations.Genetic Analysis of Neisseria meningitidis Sequence Type 7 Serogroup X Originating from Serogroup A.

P2860

Q38844408-4AAE782B-A16F-4C45-8F1A-5C2B17E3E771 Q40287241-B22527A8-1267-484E-8DED-164F1FE16DA2

P2860

Fighting Neisseria meningitidis: past and current vaccination strategies.

Item

http://www.wikidata.org/entity/Q38829564

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Fighting Neisseria meningitidis: past and current vaccination strategies.

@en

type

Item

label

Fighting Neisseria meningitidis: past and current vaccination strategies.

@en

prefLabel

Fighting Neisseria meningitidis: past and current vaccination strategies.

@en

P1476

Fighting Neisseria meningitidis: past and current vaccination strategies.

@en

P2093

Alessandro Torelli

http://www.w3.org/2001/XMLSchema#string

Elena Gianchecchi

http://www.w3.org/2001/XMLSchema#string

Emanuele Montomoli

http://www.w3.org/2001/XMLSchema#string

Giulia Piccini

http://www.w3.org/2001/XMLSchema#string

Simona Piccirella

http://www.w3.org/2001/XMLSchema#string

P2860

THE RESULTS OF THE SERUM TREATMENT IN THIRTEEN HUNDRED CASES OF EPIDEMIC MENINGITIS

NadA, a novel vaccine candidate of Neisseria meningitidis

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers

Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design

Meningococcal carriage and disease--population biology and evolution

Epidemiology and prevention of meningococcal disease

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children

The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement

Naturally occurring lipid A mutants in neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy

P304

1393-1407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/14760584.2016.1187068

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27158988

http://www.w3.org/2001/XMLSchema#string

P921

Neisseria meningitidis

Fighting Neisseria meningitidis: past and current vaccination strategies.

about

P2860

P2860

Fighting Neisseria meningitidis: past and current vaccination strategies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921